Trials / Conditions / WHO Grade 2 Glioma
WHO Grade 2 Glioma
4 registered clinical trials studyying WHO Grade 2 Glioma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas NCT06964737 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Terminated | Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy NCT04650204 | Mayo Clinic | Phase 4 |
| Recruiting | A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma NCT04166409 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Muta NCT03212274 | National Cancer Institute (NCI) | Phase 2 |